241 related articles for article (PubMed ID: 35665023)
21. Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS.
Anastasilakis AD; Pepe J; Napoli N; Palermo A; Magopoulos C; Khan AA; Zillikens MC; Body JJ
J Clin Endocrinol Metab; 2022 Apr; 107(5):1441-1460. PubMed ID: 34922381
[TBL] [Abstract][Full Text] [Related]
22. Non-antiresorptive drugs associated with the development of medication-related osteonecrosis of the jaw: a systematic review and meta-analysis.
Suryani IR; Ahmadzai I; Shujaat S; Ma H; Jacobs R
Clin Oral Investig; 2022 Mar; 26(3):2269-2279. PubMed ID: 35013781
[TBL] [Abstract][Full Text] [Related]
23. Location and Gender Differences in Osteonecrosis of the Jaws in Patients Treated with Antiresorptive and Antineoplastic Drugs Undergoing Dentoalveolar Surgical, Systematic Review with Meta-Analysis and Trial Sequential Analysis.
Dioguardi M; Spirito F; Alovisi M; Aiuto R; Garcovich D; Crincoli V; Ballini A; Caloro GA; Lo Muzio L
J Clin Med; 2023 May; 12(9):. PubMed ID: 37176741
[TBL] [Abstract][Full Text] [Related]
24. Medication-Related Osteonecrosis of the Jaw: A Cross-Sectional Survey among Urologists in Switzerland, Germany, and Austria.
Calderaro S; Bausch K; Tourbier C; Wetterauer C; Thieringer FM; Berg BI
J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675567
[TBL] [Abstract][Full Text] [Related]
25. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review.
Kawahara M; Kuroshima S; Sawase T
Int J Implant Dent; 2021 May; 7(1):47. PubMed ID: 33987769
[TBL] [Abstract][Full Text] [Related]
26. Dental implants as risk factors for patients with medication-related osteonecrosis of the jaws (MRONJ).
Pichardo SEC; van der Hee JG; Fiocco M; Appelman-Dijkstra NM; van Merkesteyn JPR
Br J Oral Maxillofac Surg; 2020 Sep; 58(7):771-776. PubMed ID: 32631756
[TBL] [Abstract][Full Text] [Related]
27. Occurrence and risk indicators of medication-related osteonecrosis of the jaw after dental extraction: a systematic review and meta-analysis.
Gaudin E; Seidel L; Bacevic M; Rompen E; Lambert F
J Clin Periodontol; 2015 Oct; 42(10):922-32. PubMed ID: 26362756
[TBL] [Abstract][Full Text] [Related]
28. Risk of healing impairment following tooth extraction in patients administered with antiresorptive and non-antiresorptive polypharmacy.
Suryani IR; Shujaat S; Ivković U; Coucke W; Coropciuc R; Jacobs R
J Stomatol Oral Maxillofac Surg; 2024 Apr; 125(2):101645. PubMed ID: 37748709
[TBL] [Abstract][Full Text] [Related]
29. Medication-related osteonecrosis of the jaw-like lesions in rodents: A comprehensive systematic review and meta-analysis.
Kuroshima S; Sasaki M; Murata H; Sawase T
Gerodontology; 2019 Dec; 36(4):313-324. PubMed ID: 31373407
[TBL] [Abstract][Full Text] [Related]
30. Is serum C-terminal telopeptide cross-link of type 1 collagen a reliable parameter for predicting the risk of medication-related osteonecrosis of the jaws? A systematic review and meta-analysis of diagnostic test accuracy.
Traboulsi-Garet B; Jorba-García A; Camps-Font O; Alves FA; Figueiredo R; Valmaseda-Castellón E
Clin Oral Investig; 2022 Mar; 26(3):2371-2382. PubMed ID: 35124731
[TBL] [Abstract][Full Text] [Related]
31. Awareness of Medication-Related Osteonecrosis of the Jaws Amongst Patients on Antiresorptive and Antiangiogenic Medications.
Assari AS; Alanazi Y; Mubarak Algharbi E; Abuhabsha A; Alshammry B; Alzahrani A; Alduhaim A; Abuhaimed R
Cureus; 2024 Jan; 16(1):e52896. PubMed ID: 38406100
[TBL] [Abstract][Full Text] [Related]
32. Combined Administration of Bisphosphonates, Chemotherapeutic Agents, and/or Targeted Drugs Increases the Risk for Stage 3 Medication-Related Osteonecrosis of the Jaw: A 4-Year Retrospective Study.
Zhou Y; Yu Y; Shi Y; Li M; Yang C; Wang S
Biomed Res Int; 2020; 2020():5847429. PubMed ID: 33123580
[TBL] [Abstract][Full Text] [Related]
33. Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents.
Hauer L; Jambura J; Hrusak D; Chalupova M; Posta P; Rusnak S; Vyskocil V
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):100-107. PubMed ID: 30647474
[TBL] [Abstract][Full Text] [Related]
34. Dentists' Awareness of Medication-Related Osteonecrosis of the Jaw (Risk Factors, Drugs, and Prevention) in the Republic of Croatia.
Bival S; Šimović L; Blažun A; Bergman L; Vražić D; Granić M
Acta Stomatol Croat; 2023 Jun; 57(2):121-132. PubMed ID: 37427357
[TBL] [Abstract][Full Text] [Related]
35. Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases.
Ikesue H; Doi K; Morimoto M; Hirabatake M; Muroi N; Yamamoto S; Takenobu T; Hashida T
Cancer Chemother Pharmacol; 2021 Jun; 87(6):871-877. PubMed ID: 33791853
[TBL] [Abstract][Full Text] [Related]
36. Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention.
Owosho AA; Liang STY; Sax AZ; Wu K; Yom SK; Huryn JM; Estilo CL
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):440-445. PubMed ID: 29580668
[TBL] [Abstract][Full Text] [Related]
37. [Management of medication-related osteonecrosis of the jaw-a review of recent study results in comparison to established strategies].
Tröltzsch M; Tröltzsch M; Pautke C; Otto S
HNO; 2022 Jul; 70(7):499-507. PubMed ID: 35050392
[TBL] [Abstract][Full Text] [Related]
38. Effect of Antiresorptive Drugs on Osseointegrated Dental Implants: A Systematic Review.
Li JTW; Leung YY
J Clin Med; 2024 Apr; 13(7):. PubMed ID: 38610856
[No Abstract] [Full Text] [Related]
39. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
Dodson TB
Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367
[TBL] [Abstract][Full Text] [Related]
40. Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab.
Wick A; Bankosegger P; Otto S; Hohlweg-Majert B; Steiner T; Probst F; Ristow O; Pautke C
Clin Oral Investig; 2022 Mar; 26(3):2839-2852. PubMed ID: 34812959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
